SCHEMBL32678129

SCHEMBL32678129

Nc1nc2ccc(C(=O)N3CCC4(CCOC4)C3)cc2s1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 2/20 0.59
▸ CYP1A2 P05177 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ GPR183 P32249 10/20 0.48
▸ KCNH2 Q12809 1/20 0.48
▸ HPGD P15428 2/20 0.47
▸ TSHR P16473 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ NPC1 O15118 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ DRD2 P14416 1/20 0.43
▸ PIK3CA P42336 1/20 0.43
▸ ENPP2 Q13822 1/20 0.42
▸ ATXN2 Q99700 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32678126 1.00 CRBN (0.59) CRBNCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL3089549 0.80 HPGD (0.65) CRBNCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL32678089 0.80 CRBN (0.62) CRBNCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL32678086 0.80 CRBN (0.62) CRBNCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL32678135 0.77 LMNA (0.50) CRBNCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL32678133 0.77 LMNA (0.50) CRBNCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL32678209 0.77 CRBN (0.60) CRBNCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL32678212 0.77 CRBN (0.60) CRBNCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL32678152 0.76 CYP1A2 (0.67) CRBNCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL557523 0.76 CYP1A2 (0.67) CRBNCYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026043617-A1 COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF HEALTH CONDITIONS AND DRUG SCREENING REGLAGENE, INC. (US) 2026-02-26 — — WO disclosed
Send feedback